Oct 9 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX RECEIVES POSITIVE DSMB RECOMMENDATION FOR MONTELUKAST VERSAFILM® PHASE 2A TRIAL
* INTELGENX TECHNOLOGIES CORP - WITH NO SAFETY CONCERNS, DSMB RECOMMENDS TRIAL CONTINUES; DOSE INCREASE PLANNED
* INTELGENX TECHNOLOGIES CORP - DSMB DID NOT RAISE ANY CONCERNS REGARDING SAFETY AND RECOMMENDED THAT TRIAL CONTINUE.